/PRZWT/Suzhou, July 22, 2024 - In the map of China's economic development, the Yangtze River Delta region has become an important growth pole of the national economy with its strong growth momentum and integrated development strategy. In this dynamic zone, Xu Haoyu, Secretary of the Party Committee, Chairperson and President of Yangzijiang Pharmaceutical Group, has always adhered to the mission of "seeking progress and protecting all sentient beings", led the group to actively implement the requirements of the "Outline of Building a Quality Power", and unswervingly followed the path of strong quality industry and brand leadership, and vigorously promoted the upgrade of the pharmaceutical manufacturing industry.
An excellent brand cannot do without high-quality products and high-quality services. Since its establishment 53 years ago, Yangzijiang Pharmaceutical has adhered to the deep cultivation of the field of medicine and health, deeply integrating traditional Chinese medicine, chemical medicine, biological medicine and big health industry chain, and conducting all-round quality control. Under the leadership of Xu Haoyu, Yangzijiang Pharmaceutical has continuously upgraded its quality through quality improvement, industrial upgrading and reengineering, and set a quality benchmark for the field of medicine and health. It has drawn a full-chain industrial map from the ground to the shelf, supported by high-quality products and services.
Xu Haoyu promoted the introduction that Yangzijiang Pharmaceutical Group insists on holding "Quality Month" activities every year. Through the "Double Quality Month" activities for more than 20 consecutive years, the group has expanded quality control from a single product dimension to the whole field and whole process of enterprise management, built a quality ecosystem with full participation, effectively broadened the breadth and depth of quality management, and created more than 500 million yuan of economic benefits through more than 130 quality management (QC) activity groups. Many topics have successfully filled the technical gap at home and abroad.
After years of exploration and practice, Yangzijiang Pharmaceutical Group has accumulated valuable experience in the field of quality management. With its leading position in the industry and deep understanding of quality management, the group has participated in the formulation of more than 300 national standards for medicines; it has won the total number of first prizes in the national quality management (QC) group activities "19 consecutive titles", highlighting the group's outstanding achievements in quality management. At the same time, Yangzijiang Pharmaceutical Group has innovatively established a drug quality risk control model, extending quality supervision to the entire industrial chain, ensuring the safety and effectiveness of patient medication from the source to the end point. This model has been adopted as a local standard in Jiangsu Province, effectively promoting the steady improvement of industrial quality competitiveness.
Under the continuous promotion of Xu Haoyu, Yangzijiang Pharmaceutical Group has gradually integrated with international production quality management standards. Through a series of high-frequency benchmarking and rectification measures, it has ensured high standards of product quality and safety. It has successively obtained European Union GMP and Australian TGA GMP certification, establishing a good international reputation.
Talking about the future, Xu Haoyu said that he will continue to adhere to the principle of quality first, constantly shape and improve brand perception, and is committed to injecting more "China Yangtze River power" into the global health cause.
